Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

This study has been terminated.

( Repros decided to stop the study because of safety and the FDA decided to put the study on hold because of safety. )

Study NCT00683917 Information provided by Repros Therapeutics Inc.

First Received: May 22, 2008 Last Updated: August 11, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	March 2010
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)